Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bob-loblaw
    Member
    • Jun 2012
    • 59

    #1

    RNA-Seq spliced aligners. Exon first vs Seed extend

    Hi guys.

    I was just wondering about some peoples opinions on RNA-Seq aligning methods. Maybe I'm misunderstanding it but I would think that seed extend aligners like STAR are inherently better, since they are able to make a decision on if something is spliced or unspliced. (And have the added benefit of being more suitable for mapping to a combination of human and bacteria, if one was looking at a host-pathogen interaction or something). As opposed to exon first methods (like Tophat) which map reads continuously first then deal with the spliced alignments after (which I think would bias the reads to map continuously).

    What do you think?

    Here is a good nature methods review discussing it for those that are interested but don't know about aligners. http://www.nature.com/nmeth/journal/...d=NMETH-201106
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I tend to agree. You might want to read through this paper, also from Nature Methods, that came to similar conclusions.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:52 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...